tiakis Biotech AG has partnered with Northway Biotech to scale up its production capabilities.
January 2022 –
tiakis Biotech AG (formerly Proteo Biotech AG) has announced that the Company has partnered with a new CMO Northway Biotech in Vilnius, Lithuania (https://www.northwaybiotech.com) to commence a tech transfer of its innovative Tiprelestat production processes.
The Company is highly confident that this will open the door to a further expansion of its clinical development programs and to anticipate future demands for its investigational medical product Tiprelestat.
Ramp-up of the production capabilities is expected to be completed in Q4 2022.
tiakis BIOTECH AG
phone: +49 431 8888-462
fax: +49 431 8888-463